MedPath

HYDROXYZINE PAMOATE

Hydroxyzine Pamoate Capsules USP

Approved
Approval ID

b6a5fb1e-b133-452d-ba97-84c1cca03fc1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 3, 2012

Manufacturers
FDA

STAT Rx USA LLC

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

HYDROXYZINE PAMOATE

PRODUCT DETAILS

NDC Product Code16590-357
Application NumberANDA087479
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateOctober 3, 2012
Generic NameHYDROXYZINE PAMOATE

INGREDIENTS (13)

HYDROXYZINE PAMOATEActive
Quantity: 25 mg in 1 1
Code: M20215MUFR
Classification: ACTIR
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C GREEN NO. 3Inactive
Code: 3P3ONR6O1S
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
HYDROXYPROPYL CELLULOSEInactive
Code: RFW2ET671P
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
HYDROXYZINE PAMOATE - FDA Approval | MedPath